EAST END GROUP, LLC

Lobbying for BAVARIAN NORDIC INC. · Biotechnology pharmaceutical product discovery and development.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Legislatives issues related to biodefense preparedness and response. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.